NCT02203006View on ClinicalTrials.gov

HIV Patients Cohort

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,613

Participants

Timeline

Start Date

October 19, 2011

Primary Completion Date

October 31, 2030

Study Completion Date

April 30, 2031

Conditions
Patients Affected by the HIV
Interventions
BIOLOGICAL

OVIHD

7 ml of blood will be taken during a follow-up consultation and kept in a biological collection. Clinical data will be collected in a database.

Trial Locations (1)

75004

Hôpital Hôtel Dieu, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02203006 - HIV Patients Cohort | Biotech Hunter | Biotech Hunter